about
Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.The N-glycan profile of placental membrane glycoproteins alters during gestation and aging.Characterisation of N-glycans bound to IGFBP-3 in sera from healthy adults.Alterations of insulin-like growth factor binding protein 3 (IGFBP-3) glycosylation in patients with breast tumours.The insulin-like growth factor system in the circulation of patients with viral infections.The influence of laparoscopic and open surgery on the concentration and structural modifications of insulin-like growth factor binding protein 3 in the human circulation.The change in the circulating insulin-like growth factor binding protein 1 isoform pattern during the course of oral glucose tolerance test.Reactivity of IGF binding protein-3 isoforms towards concanavalin A in healthy adults and subjects with cirrhosis.Insulin-like growth factors in patients with liver cysts.Insulin-like growth factor I (IGF-I) as a sensitive biomarker of catabolism in patients with gastrointestinal diseases.The effect of laparoscopy on the IGF system in patients diagnosed with acute cholecystitis.Efflux of cholesterol and phospholipids derived from the haemoglobin-lipid adduct in human red blood cells into plasma.Separation of the molecular forms of the insulin-like growth factor (IGF)-Binding proteins by affinity chromatography.Radiocesium accumulation in mosses from highlands of Serbia and Montenegro: chemical and physiological aspects.Detection and identification of oxidized insulin-like growth factor-binding proteins and receptors in patients with colorectal carcinoma.Influence of placental mannose/n-acetyl glucosamine-binding proteins on the interaction of insulin and insulin-like growth factors with their receptors.Molecular forms of the insulin-like growth factor-binding protein-2 in patients with colorectal cancer.Extraction of caesium from mosses and incorporation into an oxalate crystalline latticeGastrointestinal inflammation and the circulating IGF system in humansAlterations of IGF-binding proteins in patients with alcoholic liver cirrhosisSerum insulin-like growth factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosisInsulin-like growth factors and their binding proteins in the circulation of patients with echinococcosis, trichinellosis and toxoplasmosisDifferential influence of open surgery and sepsis on the circulating insulin-like growth factors and their binding proteins as representative metabolic markersAffinity modulation of human placental insulin and insulin-like growth factor receptors by lectinsNew considerations for IGFBP-3 determination in human serumAssociation between the pattern of IGFBP-1 alteration and the glucose/insulin metabolic controlPosttranslational modifications of the insulin-like growth factor-binding protein 3 in patients with type 2 diabetes mellitus assessed by affinity chromatographyInteraction of insulin-like growth factor-binding protein 2 with α2-macroglobulin in the circulationThe importance of metal ions for the formation and isolation of insulin-like growth factor-binding protein 3-transferrin (IGFBP-3-Tf) complexes, and the analysis of their physiological involvementComplexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumorIGFBP-3/transferrin/transferrin receptor 1 complexes as principal mediators of IGFBP-3 delivery to colon cells in non-cancer and cancer tissuesProtein molecular forms of insulin-like growth factor binding protein-2 change with agingFibrinogen Increases Resveratrol Solubility and Prevents it from Oxidation
P50
Q38108373-1119EEA1-3D8C-4A2F-90CC-449C9ECC7537Q39251073-63CFAFE8-DE23-4294-9FA0-1A4B45A453CEQ39942064-76B9DFC8-1BD2-4B4D-943E-82C34820D756Q43122072-90F4FC5B-DEBC-47E0-B581-FB4F0F7D094FQ43715330-DED23B2A-CD28-4C18-8DE0-1311356DF2E4Q43915764-4D01819E-3AC8-48CE-BDA4-77F659EC4900Q44336037-727D5426-8539-4B6C-B6F5-88181EA25C1FQ44439982-F155B500-4155-4463-84E7-ECBB81FE50A0Q45150530-55D07577-9A1B-482C-9312-B7348F954B7CQ50160204-AD9E0C9A-B54F-4F65-ACA1-E3A79553A4ACQ50163871-5BC00B88-D2BF-40EE-A721-98927AEB2C4AQ50705828-E5979D7E-E635-45C0-A7D9-F7F3E524C7CDQ51808056-ADD3EAAD-4ADC-4078-9AC2-32816ECE1DB9Q53327103-E4BFBBF0-622D-47EB-886F-BEB9FFA8D650Q54408064-044A0365-4CCF-4898-B493-D8217327E031Q54550125-CE690AFB-1F1F-4C7E-B5BB-2DE01B59C43DQ54585184-A5F74BD5-7626-47C3-9B72-FD8EA27A0E8AQ57756357-DE057D0D-3571-49F4-BA63-7810C57FA9B8Q64378044-FD97D17E-BACA-4886-BC03-2858F0224783Q73222712-42823A9F-3229-42BC-AA9D-BA3EA64771B7Q73571856-910DF7F6-3789-49FF-AA6B-E69B82215646Q73826543-9A7C7874-A8DB-472B-8108-8EB1EAF4BD5BQ80782275-845FD2DC-D2AA-4ACE-9F56-8DEF6D414542Q80811070-BBF4D5DC-6566-4DAF-9525-015043DD552CQ81016935-112984FB-8C60-44A6-9E5E-454E90439ED3Q82589634-859C85DA-FD9C-4EA2-AB47-9BCC42C22414Q84775580-61A3F623-1DD9-4939-831A-00CAF4C9ABFFQ86090504-8C12F7D6-794E-4860-A35A-B7E5965804DEQ86102734-6B7D2230-DA4E-4AA6-AEBB-1B60A1F4F28CQ86880133-523508C8-9616-4AE6-90AE-AC3E08D959D9Q87049212-9BF84A15-1362-4719-8363-AC45F57EE1F5Q87530413-64815663-AD16-42B4-A82C-797D4458E897Q96428295-878041BB-FD68-4CDE-AFCE-3EF1FFEDA47D
P50
description
researcher
@en
name
O Nedić
@en
O Nedić
@nl
type
label
O Nedić
@en
O Nedić
@nl
prefLabel
O Nedić
@en
O Nedić
@nl
P106
P31
P496
0000-0003-2042-0056